StockData
Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc. (COCP) stock

COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.01+0.03 (+3.30%)

Close on Nov 17, 2026Market cap $19.46MP/E –Yield –

Cocrystal Pharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Cocrystal Pharma's price to book ratio was 13.5× on Nov 11, 2026, against 1.8× a year earlier. Over the last 5 years it ranged from 0.0× to 15.3×, with a median of 1.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202613.5×+11.8
2025Dec 31, 20251.7×+0.0
2024Dec 31, 20241.6×+1.0
2023Dec 29, 20230.6×+0.5
2022Dec 30, 20220.0×−0.8
2021Dec 31, 20210.8×−1.1
2020Dec 31, 20201.9×+1.6
2019Dec 31, 20190.2×−0.7
2018Dec 31, 20181.0×−0.5
2017Dec 29, 20171.5×−0.2
2016Dec 30, 20161.7×−1.5
2015Dec 31, 20153.1×+3.1
2014Dec 31, 20140.0×–

More Cocrystal Pharma figures

See a number that looks wrong?